She went from a VP role at Pharmacyclics to a VP role at Onyx. Then she was demoted to US Brand Lead of Kyprolis, then further demoted to the useless supportive care oncology brands of Amgen. Where does her slide stop? Will she be hired away somewhere Or will she be demoted to director of even lesser brands? I say she leaves Amgen for another shitty job but at least she doesn't have to lick Richard Paulson and Tony Hooper's cajons anymore.
She she moved to TO in Sep 2015, she will be out of Amgen by end of 2017 at the latest unless another company buys her SF to TO Relo package. By mid next year, she would only have to pay back 25% meaning she will likely get another job at the VP level and make that company pay for the relocation package.